Abstract:Background: Carcinogenesis is a process in which uncontrolled cell proliferation forms preneoplastic nodules which precede the appearance of cancer. In normal cells, growth and proliferation are regulated by certain growth and hormonal stimulation, while mutational alterations in these signals render the cells independent and resistant to these signals. In cancer, the critical homeostatic balance between cell growth and apoptosis is lost and the cells continue to survive beyond their normal life span. The activation of c-Jun N-terminal kinase (JNK), p38 and caspases are involved in potential proapoptotic signaling pathways. JNK, p38 MAPK pathway and caspases play a crucial role in the control of apoptosis in response to stress. Outline: The most recent and up-to-date literature was evaluated in this study, which describes the role of JNK, p38 MAPK pathway and caspases as therapeutic target in cancer. Chemotherapy uses drugs that are cytotoxic to highly proliferating tumor cells but also kills the non-tumor rapidly proliferating cells in the hair, skin and gastrointestinal tract epithelium, thereby accounting the side effects of these types of treatments. Recently, chemopreventive modalities derived from phytoconstituents present in plants provide a broad-spectrum strategy to overcome the incidence of cancer. Non-toxic, safe and affordable bioavailabilities of chemopreventive agents provide credence support in the field of cancer research compared to conventional therapies that cause serious consequences. Chemoprevention envisages the basic mechanisms like modulating the activity of xenobiotic-metabolizing enzymes, induction of apoptosis, immune system activation, suppressing angiogenesis and the formation of metastasis, antioxidant and anti-inflammatory properties. Conclusion: The present review highlighted the role of phytoconstituents derived from food, vegetables and medicinal plants in the induction of apoptosis in cancer cells, which in turn is mediated by the activation of JNK, p38 MAPK pathways, and caspases.

Therapeutic potential of ASK1 activators in cancer treatment: Current insights and future directions

The Role and Regulation of Apoptosis Signal-Regulated Kinase 1 in Liver Disease

Apoptosis Signal-Regulating Kinase 1 Exhibits Oncogenic Activity in Pancreatic Cancer

Ecliptasaponin A induces apoptosis through the activation of ASK1/JNK pathway and autophagy in human lung cancer cells.

Discovery of Potent Apoptosis Signal-Regulating Kinase 1 Inhibitors Via Integrated Computational Strategy and Biological Evaluation

Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and P38 Signaling Pathways

Catalytic activity in vitro of the human protein kinase ASK1 mutants: Experimental and molecular simulation study

The regulatory and signaling mechanisms of the ASK family

Selective Inhibitors for JNK Signalling: a Potential Targeted Therapy in Cancer

Small Molecules Targeting Activated Cdc42-Associated Kinase 1 (ACK1/TNK2) for the Treatment of Cancers

Design, Synthesis and Biological Evaluation of 1H-Indazole Derivatives As Novel ASK1 Inhibitors.

Cancer Therapy : Preclinical Sphingosine Kinase-1 Enhances Resistance to Apoptosis through Activation of PI 3 K / Akt / NFk B Pathway in Human Non – Small Cell Lung Cancer

c-Jun N-terminal kinase (JNK), p38, and Caspases: Promising Therapeutic Targets for the Regulation of Apoptosis in Cancer Cells by Phytochemicals

p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents.

Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives.

Negative Control of Apoptosis Signal-Regulating Kinase 1 Through Phosphorylation of Ser-1034

Antagonists of IAP proteins: novel anti-tumor agents.

Apoptosis Signal-regulating Kinase 1 Promotes Ochratoxin A-induced Renal Cytotoxicity

Targeting ASK1 by CS17919 alleviates kidney- and liver-related diseases in murine models.

The potential of activator protein 1 (AP-1) in cancer targeted therapy

Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy